Birmingham-based Molecular Designs, a leading provider of PCR assays, associated reagents and equipment, has acquired Lamda Biotech, a provider of research products for application in molecular biology, functional genomics, proteomics and gene therapy. This partnership will enhance Molecular Designs' product portfolio, grow its reach into academic research and pharma market segments, and further expand its talent base of specialized personnel.
For more than 20 years, Lamda Biotech has offered cutting-edge PCR products, RT-PCR reagents, RT-qPCR kits, Direct-PCR genotyping kits, DNA ladders, SafeStain, and other protein and cell biology products. Molecular Designs will leverage its manufacturing capabilities to scale Lamda's product offerings, enhance new product R&D, and increase access to customers through added distribution channels, which will solidify Molecular Designs' position as a key player in the molecular technology market.